Pharmacopsychiatry

Papers
(The TQCC of Pharmacopsychiatry is 2. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)
ArticleCitations
28
SARS-CoV-2-Infection in People Addicted to Illegal Drugs – Is There a Protective Effect of Opioid Maintenance Treatment?27
The Role of Circadian Rhythmicity and CLOCK Genes in Psychiatry22
Time-Dependent Effects of Metformin and Olanzapine on the Metabolic System17
Effects of a citalopram treatment on the amyloid-β-pathology and behaviour in the 5xFAD Alzheimer mouse model16
2001–2021 Comparative Persistence of Oral Antipsychotics in Patients Initiating Treatment: Superiority of Clozapine in Time-to-Treatment Discontinuation14
The Effect of Kidney Function and Cardiovascular and Anti-Inflammatory Comedications on the Serum Concentration of Risperidone under Naturalistic Conditions14
Utility of Antidepressant Randomized Controlled Trials for Regular Treatment13
Twenty-Three Years of Declining Lithium Use: Analysis of a Pharmacoepidemiological Dataset from German-Speaking Countries13
Exposure to Psychotropic Drugs and Colorectal Cancer Risk in Patients with Affective Disorder: A Nested Case-Control Study12
The Mini-TRH Test11
Challenges Related to the Implementation of Measurement-Based Care for the Treatment of Major Depressive Disorder: A Feasibility Study11
Escitalopram and Clonazepam Affect Gasotransmitter-related Enzyme (nNOS, HO-2, CBS) Gene Expression in the Rat Brain11
Psychiatric syndromes associated with anti-neural autoantibodies differ in their affective psychopathology from those that are not10
The Role of Mood Stabilizers in Children and Adolescents with Anorexia Nervosa: A 1-year Follow-Up, Propensity Score-Matched Study10
Neutral sphingomyelinase is a major driver of sex-differences in depression and alcohol-abuse9
8
The Endocannabinoid System in PTSD: Molecular Targets for Modulating Fear and Anxiety8
News on the Role of Antidepressants in and for COVID-19 and Long COVID7
7
Recreational Cannabis Legalization: No Contribution to Rising Prescription Stimulants in the USA7
Mineralocorticoid and glutamatergic NMDA receptor stimulation does not influence spatial learning and memory in depressed individuals and healthy control7
POMC and NR3C1-1F DNA methylation in major depressive disorder and electroconvulsive therapy6
Can Red Blood Cell Membrane Fatty Acids Predict Intracellular Lithium Concentration in Bipolar Disorder? A Cross-Sectional Study6
6
GABAergic Effects of Etifoxine and Alprazolam Assessed by Double Pulse TMS6
Patient and Physician Exposure to Artificial Intelligence Hype5
Social Robots in Psychiatry for Patients Suffering from Major Depression—A Pilot Study5
Intestinal Flora and Depression: Interaction Mechanisms and Therapeutic Prospects5
Ausschreibung Peter Müller Preis für Forschung im Bereich Schizophrenie5
Bariatric surgery: impact on oral aripiprazole and fluoxetine bioavailability – A clinical case4
Artificial Intelligence in Drug Discovery and Development: Raising Quality per Decision4
4
Prevalence of COVID-19 and Psychotropic Drug Treatment in Psychiatric In-patients in Germany in 2020: Results from a Nationwide Pilot Survey4
Vitamin D: Adjustment of Per1 expression in study participants with an ADHD diagnosis4
Effects of Anesthesia Changes During Maintenance ECT: A Longitudinal Comparison of Seizure Quality Under Anesthesia Using Propofol/Esketamine Versus Methohexita3
A retrospective comparison of etomidate and methohexital as anesthetic agents for maintenance electroconvulsive therapy3
Cardiac Consequences Associated with Psychedelic Use: A Systematic Review of Lysergic Acid Diethylamide, 3,4-Methylenedioxymethamphetamine, and 5-Hydroxytryptamine 2B-Mediated Valvular Heart Disease3
Cardiovascular Effects of Non-Selective Monoamine Oxidase Inhibitors and Intranasal Esketamine Combination in Depression – A Quasi-Experimental Design with Baye3
Xanomeline-Trospium for Adults with Schizophrenia Experiencing Acute Psychosis: A Systematic Review and Meta-analysis of Safety and Tolerability Outcomes3
3
Does Lidocaine Shorten Seizure Duration in Electroconvulsive Therapy?3
Guideline adherence in patients with long-term schizophrenia in Germany: Focus on clozapine and electroconvulsive therapy3
Association between Intravenous Ketamine Treatment and Cognitive Function in Patients with Treatment-Resistant Depression: A Double-Blind, Randomized, Placebo-C3
Perceptions, Experiences, and Patterns of Cannabis Use in Individuals with Mood and Anxiety Disorders in the Context of Cannabis Legalization and Medical Cannab3
Increased Odds of Cognitive Impairment in Adults with Depressive Symptoms and Antidepressant Use3
Regulatory Alignment of Psilocybin Clinical Trials in Major Depressive Disorder on ClinicalTrials.gov: A Cross-Sectional Analysis3
Overview: Chronic Pain and Cannabis-Based Medicines3
The Relevance of Integrating CYP2C19 Phenoconversion Effects into Clinical Pharmacogenetics3
Functional connectivity analysis of locus coeruleus in patients with major depressive episode2
Development of a Genetic Test Indicating Increased AVP/V1b Signalling in Patients with Acute Depression2
Revisiting the World’s Strictest COVID-19 Lockdown: Formidable Mental Health Challenges2
Major depressive episodes with high rapid eye movement density do not respond better to rapid eye movement sleep suppressive antidepressants than to others2
Blocking the Reflection: Milestones and Hurdles for Digital Twins in Mental Health2
Ausschreibung Peter Müller Preis für Forschung im Bereich Schizophrenie2
QTc interval alterations during antidepressant treatment with escitalopram and venlafaxine2
Impact of Antipsychotic Medications on Weight Gain and Eating Disorder-Related Psychopathology in Adult Inpatients with Anorexia Nervosa2
Metformin is Protective Against the Development of Mood Disorders2
2
Heart Rate-Corrected QT Interval Dynamics Following Antidepressant Switching from Escitalopram to High-Dose Venlafaxine: Cardiac Safety Insights from the Early 2
Glycine and the ketamine model of schizophrenia: Modulating the N-methyl-D-aspartate receptor (NMDAR) offers new insights into the glutamate hypothesis of schiz2
Monitoring Anesthetic Depth Using the Patient State Index in Electroconvulsive Therapy Improves Seizure Quality2
Utilizing Machine Learning to Forecast 3-Month Remission Outcomes in Bipolar Disorder Patients Treated with Lithium2
2
0.06280779838562